JT
NUVB icon

Jupiter Topco’s Nuvation Bio NUVB Stock Holding History

Jupiter Topco’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$615K Buy
+108,400
New +$530K ﹤0.01% 2005

Other funds holding NUVB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Jupiter Topco's NUVB Position: Q2 2026 in Review

Jupiter Topco opened a new position in Nuvation Bio (NUVB) in Q2 2026: 108,400 shares worth $615K. The stake represents ﹤0.01% of the portfolio and ranks #2005 among its holdings.

221 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Jupiter Topco held 108,400 shares of Nuvation Bio worth $615K as of Q2 2026.
  • Nuvation Bio was a new Jupiter Topco position in Q2 2026.
  • Nuvation Bio made up ﹤0.01% of Jupiter Topco's portfolio in Q2 2026, its #2005 holding.
  • 221 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Jupiter Topco's 13F filing for Q2 2026, filed 14 Aug 2026.